Sign up for email alert when new content gets added: Sign up
Journal of Clinical Genetics and Genomics is an open access publication aimed at understanding how genetic mutations in specific genes affect the phenotype, and how this information might be harnessed to develop new approaches to therapy. By means of the studies published, this journal aims to bridge the gap between the lab and the healthcare centers.
The Journal of Clinical Genetics and Genomics places special focus on the underlying cause of inherited diseases and genetic syndromes such as: Fragile-X Syndrome, Thalassemia, Huntington’s disease, Cystic fibrosis, Down syndrome, Mitochiondrial Disease, Muscular Dystrophy, and Patau Syndrome. Special impetus is placed on studies dealing with molecular approaches in understanding the disease pathogenesis.The journal welcomes related studies on the gene therapy to develop fitting solutions for the effective management of the disease.
Studies involving genomic studies such as: genetic mapping by next generation sequencing techniques, RNA-Sequencing, ChIP-Sequencing, and microarray are highly solicited. Further, studies concerned with diagnostic techniques such as RAPD and RFLP for screening mutations or identifying polymorphisms are also solicited.The scope of the Journal of Clinical Genetics and Genomics also encompasses articles from the fields of neurogenetics, cancer genetics, medical genetics, biochemical genetics, population genetics, genetic epidemiology, and immunogenetics.
Authors are invited to publish their findings and opinions in a variety of formats such as: research articles, short communications, case reports, letters to the editor, reviews, guidelines, and techniques.
Author(s) can submit their manuscripts through the journal's online submission and tracking system at https://www.pulsus.com/submissions/clinical-genetics-genomics.html or as an e-mail attachment at firstname.lastname@example.org
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Clinical Genetics and Genomics is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.